Australian-led trial delivers encouraging results. A landmark Australian-led phase 2 clinical trial has delivered promising results for patients with...
Vous n'êtes pas connecté
The Australian & New Zealand Children’s Haematology/Oncology Group (ANZCHOG)-sponsored OPTIMISE trial has opened to recruitment today at Sydney Children’s Hospital (SCH) and Queensland Children’s Hospital (QCH), marking a promising advancement in children’s cancer therapies utilising precision medicine. As a platform trial, OPTIMISE will be able to test the effectiveness of multiple different treatment options for [...]
Australian-led trial delivers encouraging results. A landmark Australian-led phase 2 clinical trial has delivered promising results for patients with...
According to Our World in Data, New Zealand achieved 75% coverage of the initial COVID-19 vaccination...
According to Our World in Data, New Zealand achieved 75% coverage of the initial COVID-19 vaccination...
By Lakshmy Ramakrishnan Biotechnology is a critical emerging technology holding significant potential in addressing various challenges,...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order.
bWhen the tiniest patients face the toughest beginnings, compassion can be the most powerful medicine/b. At Oklahoma Children's Hospital, a new wave
The human gut is home to trillions of microbes, yet scientific understanding has largely focused on bacteria, leaving the virome—the community of...
“Cell-based therapies are the most advanced and promising treatments for cancer," says Didsbury, who is an immunologist, committee chair at the...